Effect of Granulocyte-colony stimulating factor with or without Moxifloxcacin therapy on capsulated Staphylococcus aureus infection in neutropenic mice

Main Article Content

Maysem Sami Abdulalkareem

Abstract

Twenty bacterial isolates were identified as Staphylococcus aureus collected from wounds and catheters related infections. A capsulated S. aureus isolate was chosen after performing serum soft agar test, for this study Neutropenic mice were challenged with capsulated S. aureus ,and the effect of G-CSF with or without moxifloxacin was studied.
The results indicated that the addition of G-CSF to moxifloxacin therapy have a synergistic effect in the killing of the bacteria, while when each G-CSF and moxifloxacin were used seperately have a similar effect on bacterial killing. It was found that the moxifloxacin has the same activity as G_CSF but is less costly than the latter one.

Article Details

How to Cite
1.
Effect of Granulocyte-colony stimulating factor with or without Moxifloxcacin therapy on capsulated Staphylococcus aureus infection in neutropenic mice. Baghdad Sci.J [Internet]. 2010 Dec. 5 [cited 2024 Dec. 19];7(4):1338-42. Available from: https://bsj.uobaghdad.edu.iq/index.php/BSJ/article/view/1110
Section
article

How to Cite

1.
Effect of Granulocyte-colony stimulating factor with or without Moxifloxcacin therapy on capsulated Staphylococcus aureus infection in neutropenic mice. Baghdad Sci.J [Internet]. 2010 Dec. 5 [cited 2024 Dec. 19];7(4):1338-42. Available from: https://bsj.uobaghdad.edu.iq/index.php/BSJ/article/view/1110